Plain-English translation of NCT07087106 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Researchers at Brigham and Women's Hospital are studying how the brain uses glucose (its main fuel) in people with multiple sclerosis. They'll use a special imaging scan called -PET to measure this energy use in three groups: people with progressive MS, people with relapsing-remitting MS, and healthy volunteers with no MS. This scan might help doctors better understand what's happening in the MS brain and could lead to better ways to detect or monitor the disease.
Scientists want to understand why different types of MS progress differently and whether measuring brain energy use could help identify the disease earlier or track how well treatments are working. Right now, doctors don't have a clear way to see these differences in brain activity.
You likely qualify if…
You likely don't qualify if…
You would visit the research center for 3–4 appointments over several weeks. At your first visit, you'll complete some questionnaires about your health and memory, sign consent forms, and have blood drawn for future testing. At subsequent visits, you'll have a PET scan and an MRI scan — both are painless imaging tests that take pictures of your brain to measure how it uses energy. The whole process is non-invasive; no medications or procedures will be given.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States